CIGARETTE SMOKING IS ASSOCIATED WITH DECREASED MORTALITY IN CRITICALLY ILL TRAUMA PATIENTS.
Journal
Shock (Augusta, Ga.)
ISSN: 1540-0514
Titre abrégé: Shock
Pays: United States
ID NLM: 9421564
Informations de publication
Date de publication:
01 08 2022
01 08 2022
Historique:
pubmed:
24
1
2022
medline:
30
9
2022
entrez:
23
1
2022
Statut:
ppublish
Résumé
Background: Smoking may offer pathophysiologic adaptations that increase survivability in certain patients with cardiovascular disease. We sought to identify if smoking increases survivability in trauma patients, hypothesizing that critically ill trauma patients who smoke have a decreased risk of mortality compared with non-smokers. Methods: The Trauma Quality Improvement Program (2010-2016) database was queried for trauma patients with intensive care unit admissions. A multivariable logistic regression model was performed. Results: From the 630,278 critically ill trauma patients identified, 116,068 (18.4%) were current cigarette smokers. Critically ill trauma smokers, compared with non-smokers, had a higher rate of pneumonia (7.8% vs. 6.9%, P< 0.001) and lower mortality rate (4.0% vs. 8.0%, P< 0.001). After controlling for covariates, smokers had a decreased associated risk of mortality compared with non-smokers (OR = 0.55, CI = 0.51-0.60, P< 0.001), and no difference in the risk of major complications (OR = 0.98, CI = 0.931.03, P = 0.44). The same analysis was performed using age as a continuous variable with associated decreased risk of mortality (OR 0.57 (CI 0.53-0.62), P< 0.001). Conclusion: Critically ill trauma smokers had a decreased associated mortality risk compared with non-smokers possibly due to biologic adaptations such as increased oxygen delivery developed from smoking. Future basic science and translational studies are needed to pursue potential novel therapeutic benefits without the deleterious long-term side effects of smoking.
Identifiants
pubmed: 35066513
doi: 10.1097/SHK.0000000000001912
pii: 00024382-202208000-00001
doi:
Substances chimiques
Biological Products
0
Oxygen
S88TT14065
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
91-94Informations de copyright
Copyright © 2022 by the Shock Society.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest.
Références
Ockene IS, Miller NH: Cigarette smoking, cardiovascular disease, and stroke. Circulation 96(9):3243–3247, 1997.
Bell TM, Bayt DR, Zarzaur BL: “Smoker’s paradox” in patients treated for severe injuries: lower risk of mortality after trauma observed in current smokers. Nicotine Tob Res 17(12):1499–1504, 2015.
Wen CP, Tsai SP, Cheng TY, Chan HT, Chung WSI, Chen CJ: Excess injury mortality among smokers: a neglected tobacco hazard. Tob Control 14(suppl 1):i28–32, 2005.
Ali SF, Smith EE, Bhatt DL, Fonarow GC, Schwamm LH: Paradoxical association of smoking with in-hospital mortality among patients admitted with acute ischemic stroke. J Am Heart Assoc 2(3):e000171, 2013.
Purcell IF, Newall N, Farrer M: Lower cardiac mortality in smokers following thrombolysis for acute myocardial infarction may be related to more effective fibrinolysis. QJM 92(6):327–333, 1999.
Ovbiagele B, Saver JL: The smoking-thrombolysis paradox and acute ischemic stroke. Neurology 65(2):293–295, 2005.
Angeja BG, Kermgard S, Chen MS, McKay M, Murphy SA, Antman EM, Cannon CP, Braunwald E, Gibson CM: The smoker’s paradox: insights from the angiographic substudies of the TIMI trials. J Thromb Thrombolysis 13(3):133–139, 2002.
Barua RS, Sy F, Srikanth S, Huang G, Javed U, Buhari C, Margosan D, Aftab W, Ambrose JA: Acute cigarette smoke exposure reduces clot lysis–association between altered fibrin architecture and the response to t-PA. Thromb Res 126(5):426–430, 2010.
Nahmias J, Doben A, Poola S, Korntner S, Carrens K, Gross R: Implementation of a quality improvement project on smoking cessation reduces smoking in a high risk trauma patient population. World J Emerg Surg 11(1):15, 2016.
Ferro TN, Goslar PW, Romanovsky AA, Petersen SR: Smoking in trauma patients: the effects on the incidence of sepsis, respiratory failure, organ failure, and mortality. J Trauma 69(2):308–311, 2010.
Kaijser L, Berglund B: Effect of nicotine on coronary blood-flow in man. Clin Physiol 5(6):541–552, 1985.
Zhu B qing, Parmley WW: Hemodynamic and vascular effects of active and passive smoking. Am Heart J 130(6):1270–1275, 1995.
Brohi K, Singh J, Heron M, Coats T: Acute traumatic coagulopathy. J Trauma 54(6):1127–1130, 2003.
Nielsen VG, Hafner DT, Steinbrenner EB: Tobacco smoke-induced hypercoagulation in human plasma: role of carbon monoxide. Blood Coagul Fibrinolysis 24(4):405–410, 2013.
Gale SC, Peters JA, Murry JS, Crystal JS, Dombrovskiy VY: Injury patterns and outcomes in late middle age (5–-65): the intersecting comorbidity with high-risk activity – a retrospective cohort study. Ann Med Surg 27:22–25, 2018.
Resnick S, Inaba K, Okoye O, Nosanov L, Grabo D, Benjamin E, Smith J, Demetriades D: Impact of smoking on trauma patients. Ulus Travma Acil Cerrahi Derg 20(4):248–252, 2014.
Owings JT, Kraut E, Battistella F, Cornelius JT, O’Malley R: Timing of the occurrence of pulmonary embolism in trauma patients. Arch Surg 132(8):862–867, 1997.
Morrow LE, Jagan N, Walters RW, Plambeck RW, Oshiro M, Malesker MA: Prolonged prehospital time is a risk factor for pneumonia in trauma (the PRETRIP Study): a retrospective analysis of the United States National Trauma Data Bank. Chest 161:85–96, 2022.
Schmid M, Sood A, Campbell L, Kapoor V, Dalela D, Klett DE, Chun FK, Kibel AS, Sammon JD, Menon M, et al.: Impact of smoking on perioperative outcomes after major surgery. Am J Surg 210(2):221–229.e6, 2015.